#GTBD - Twitter Hashtag

4 days ago

LATE TO THE PENS GAME… FOR A VERY GOOD REASON. 😂💍🏒 Had to help a good friend say “yes to the dress.” 😤 #GTBD #Back42_Sports #PittsburghPenguins

0

12

Damsi1990 @damsi1990

about 1 year ago

@BartosiakJacek @A_Swidzinski @MStefan92 O zdolnosciach przemyslowych w segmencie stoczniowym pomiedzy USA vs Chiny, pieknie przedstawione w formie wizualnej USA w 1970: lider 2024: Chiny wybudowaly 1000 jednostek, USA 10..🙂 https://t.co/WluXxYEofC Dobra robota #gtbd

0

12

3

2K

Amare Türkiye @amareturkiye

almost 2 years ago

Bağırsak sağlığını destekleyen 6 beslenme alışkanlığı✅ #AmareGlobal #AmareTürkiye #RStour #SindirimSistemi #Şişkinlik #İçSesineGüven #GTBD #gidavebeslenme

0

1

0

136

Spittin Seeds @SpittinSeeds247

over 2 years ago

#GTBD Get The Bunt Down Love some small ball! Sometimes ya gotta get creative to win a ballgame. #GrowTheGame

0

2

1

0

548

Amare Türkiye @amareturkiye

over 2 years ago

Probiyotiklerin Bağırsak Sağlığı ve Bağışıklık Sistemi Üzerine Etkileri Nelerdir❓ #GTBD #gidatakviyesi #takviyeedicigidalar #probiyotik #bagirsaksagligi #bagisikliksistemi #Restour #restore #origin #amaretürkiye

0

2

0

143

Amare Türkiye @amareturkiye

almost 3 years ago

Omega-3 yağ asitleri akciğer sağlığını korumaya yardım ediyor💪🏻🫁 #GTBD #gidatakviyesi #takviyeedicigidalar #akcigersagligi #lunghealth #Omega3 #Omega3yagasitleri #DHA

0

2

0

83

Beth Chapin @chapin_mrs

over 4 years ago

@VinceBusta @SheltonSchools #GTBD Creating a culture of clarity in our schools will help move our students forward. Time for district wide vertical teaming?

0

2

0

Dytmag @dytmag

over 4 years ago

Gıda Takviyesi ve Beslenme Derneği'nin 2. Genç Diyetisyen Ödülleri yarışmasına katılmak için; #gncdyt #gtbd #dytmag Bu fırsatı kaçırmayın!

dytmag's tweet photo. Gıda Takviyesi ve Beslenme Derneği'nin 2. Genç Diyetisyen Ödülleri yarışmasına katılmak için;
#gncdyt
#gtbd
#dytmag
Bu fırsatı kaçırmayın! https://t.co/B4PXVVb6Sc

0

2

1

2

0

Brian O Mahony @Brianhemophilia

over 4 years ago

Pinachyan from CSL Behring #GTBD on why Haemophilia differs from other areas for Gene Therapy. There are safe and effective existing therapies unlike other conditions such as SMA but we have an advantage in having an existing budget stream for haemophilia so GT will involve 1/4

Brianhemophilia's tweet photo. Pinachyan from CSL Behring #GTBD on why Haemophilia differs from other areas for Gene Therapy. There are safe and effective existing therapies unlike other conditions such as SMA but we have an advantage in having an existing budget stream for haemophilia so GT will involve 1/4 https://t.co/NIzXYg0TMF

1

8

2

1

0

Brian O Mahony @Brianhemophilia

over 4 years ago

Trusheim #GTBD on the Gene Therapy journey says we have left the "valley of despair" and entered the "slope of enlightenment" on way to "plateau of sustainability". I hope the graph does not represent his expectation on GT cost- not if he wants to see sustainability !

Brianhemophilia's tweet photo. Trusheim #GTBD on the Gene Therapy journey says we have left the "valley of despair" and entered the "slope of enlightenment" on way to "plateau of sustainability".
I hope the graph does not represent his expectation on GT cost- not if he wants to see sustainability ! https://t.co/Fr5ZODEXoS

0

2

1

0

Sandra Perez Botero @SaPerezBotero

over 5 years ago · Cambridge

Del “Job to be done” al “Good to be done” : Innovación Responsable Si te resuena este concepto déjame un comentario y ayúdame a hacerlo más poderoso! #goodtobedone #gtbd #innovadoresresponsables

SaPerezBotero's tweet photo. Del “Job to be done” al “Good to be done” : Innovación Responsable

Si te resuena este concepto déjame un comentario y ayúdame a hacerlo más poderoso!

#goodtobedone #gtbd #innovadoresresponsables https://t.co/VMjVjClTyv

0

3

0

Brian O Mahony @Brianhemophilia

over 5 years ago

Monahan at #GTBD on risks inherent to Haemophilia Gene Therapy and the importance of registries especially @wfhemophilia Global GT registry

Brianhemophilia's tweet photo. Monahan at #GTBD on risks inherent to Haemophilia Gene Therapy and the importance of registries especially @wfhemophilia Global GT registry https://t.co/O4vQEfGjav

1

4

0

Brian O Mahony @Brianhemophilia

over 5 years ago

Monahan at #GTBD Conference on FDA guidance to assess risk of GT related delayed AEs

0

3

2

0

Brian O Mahony @Brianhemophilia

over 5 years ago

Monahan at #GTBD on monitoring of liver health in GT. He outlines the analyses to be performed following the recent HCC in the AMT061 FIX trial. He emphasizes importance of routine follow up with imaging and fibroscan on GT recipients

Brianhemophilia's tweet photo. Monahan at #GTBD on monitoring of liver health in GT. He outlines the analyses to be performed following the recent HCC in the AMT061 FIX trial. He emphasizes importance of routine follow up with imaging and fibroscan on GT recipients https://t.co/qJHEcCj4iS

0

2

3

0

Brian O Mahony @Brianhemophilia

over 5 years ago

Trusheim #GTBD says no perfect payment system yet devised. In US Medicaid best price rule is an obstacle to use of performance based annual payment

Brianhemophilia's tweet photo. Trusheim #GTBD says no perfect payment system yet devised. In US Medicaid best price rule is an obstacle to use of performance based annual payment https://t.co/wsoWPHyMcl

0

2

1

0

Brian O Mahony @Brianhemophilia

over 5 years ago

Trusheim at #GTBD discusses payment models including Warranty model where company will compensate payer for additional treatment required. ( In Haemophilia, option may be for company to provide the treatment as some GT companies market CFCs or subcutaneous alternatives)

Brianhemophilia's tweet photo. Trusheim at #GTBD discusses payment models including Warranty model where company will compensate payer for additional treatment required. ( In Haemophilia, option may be for company to provide the treatment as some GT companies market CFCs or subcutaneous alternatives) https://t.co/1VqOyBbZpN

0

2

1

0

Brian O Mahony @Brianhemophilia

over 5 years ago

Trusheim from MIT at #GTBD expects 65 Gene Therapies to be approved by 2030. He discussed concerns of US payers. Main concern is performance risks-paying only where the GT works